You are here

Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
New York, New York, 10029 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Colorectal Neoplasms, Liver Neoplasms
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- ECOG performance status of 0 or 1

- Histological documentation of adenocarcinoma of the colon or rectum. The primary site
must have been confirmed to be in the large bowel

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Prior systemic anticancer therapy for mCRC

- Prior hepatic surgery, chemoembolization, hepatic artery infusion, radiofrequency
ablation or cryotherapy for liver metastases

NCT00106054
Pfizer
Terminated
Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Neoplasm Metastasis, Colorectal Neoplasms
NCT00037180
All Genders
18+
Years
Multiple Sites
Colorectal Neoplasms
NCT00609622
All Genders
18+
Years
Multiple Sites
Colorectal Neoplasms
NCT00101686
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now